Возраст домена | n/a |
Дата окончания | n/a |
PR | 5 |
ИКС | |
Страниц в Google | 0 |
Страниц в Яндексе | 1 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 4722752 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Pharmaceutical Companies of Johnson & Johnson | Janssen
n/a
Explore Janssen’s innovative medical research & pharmaceutical product development practices to see how Janssen is creating a future where disease is a thing of the past.
UTF-8
169.88 КБ
32
279 симв.
239 симв.
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
Google Analytics | Нет доступа | Нет доступа | n/a |
Ссылок в Alexa | 27 |
Данные linkpad ( 23 Ноября 2014 ) | |
Количество ссылок на сайт | 113 |
Количество доменов, которые ссылаются на сайт | 39 |
Количество найденных анкоров | 13 |
Исходящие (внешние) ссылки домена | 105 |
Количество доменов, на которые ссылается сайт | 102 |
Количество исходящих анкоров | 69 |
Внешние ссылки главной страницы ( 13 ) | |
www1.actelion.com/en-rebranded/about-actelion/target-disease... | Pulmonary Hypertension |
globaltrialfinder.janssen.com | Janssen Global Trial Finder |
janssen.com/world-without-disease-accelerator | World Without Disease Accelerator |
jnj.com/global-public-health | Global Public Health |
xian-janssen.com.cn | 中文 |
janssen.com/dennis-frohlich-artist | Learn more about Dennis in “A Passion Rediscovered.” |
janssen.com/the-art-of-getting-lost | The Art of Getting Lost |
janssen.com/rhonda-fenwick-artist | “My Sanctuary in Art.” |
twitter.com/JanssenGlobal | |
youtube.com/channel/UCHOwWxMVtei89ur1JxMvOdA | youtube |
linkedin.com/company/janssen-pharmaceutical-companies-of-joh... | |
instagram.com/janssenglobal/ | <img> |
jnj.com | janssen global |
Внутренние ссылки главной страницы ( 100 ) | |
# | Back to Top |
/about | learn more |
/company | Our Company |
/careers | CAREERS |
/contact-us | CONTACT US |
/grants-giving | Grants & Giving |
/blogs | Leadership Blogs |
/news | NEWS CENTER |
/about/our-leadership | Our Leaders |
/products | Products |
/patient-safety-information | Patient Safety Information |
/sustainability | Sustainability |
/transparency | Transparency |
/cardiovascular-and-metabolism | Cardiovascular & Metabolism |
/immunology | Immunology |
/infectious-diseases-and-vaccines | Infectious Diseases & Vaccines |
/other | Other Focus Areas |
/neuroscience | Neuroscience |
/oncology | Oncology |
/patient-engagement | Patient Engagement |
/global-public-health-0 | See More > |
/explore | Our Science |
/biotherapeutics | Biotherapeutics |
/clinical-trials | Clinical Trials |
/compassionate-use-pre-approval-access | Compassionate Use & Pre-Approval Access |
/partnerships | Partnerships |
/research-and-development | Research & Development |
/career-0 | See More > |
/leadership-blogs | See More > |
/patient-engagement-0 | See More > |
/research-development | See More > |
/partnership | See More > |
/es | Español |
/fr | Français |
/pt | Português (BR) |
/it | Italiano |
/ko | 한국어 |
/ru | РУССКИЙ |
/apac/ | English |
/australia/ | English |
/india/ | English |
/japan/ | 日本 |
/korea/ | 한국어 |
/newzealand/ | English |
/emea/ | English |
/austria/ | Deutsch |
/belgium/ | English |
/belgium/fr | Français |
/belgium/nl | Nederlands |
/bulgaria/ | Български |
/croatia/ | HRVATSKI |
/czech/ | Čeština |
/denmark/ | Dansk |
/estonia/ | English |
/finland/ | Suomi |
/france/ | Français |
/germany/ | Deutsch |
/greece/ | ΕΛΛΗΝΙΚΑ |
/hungary/ | Magyar |
/ireland/ | English |
/israel/ | עברית |
/italy/ | Italiano |
/kazakhstan/ | Русский |
/latvia/ | English |
/lithuania/ | English |
/netherlands/ | Nederlands |
/norway/ | Norsk |
/poland/ | Polski |
/portugal/ | Português |
/romania/ | Română |
/russia/ | Русский |
/serbia/ | SRPSKI |
/slovakia/ | SLOVENČINA |
/slovenia/ | Slovenščina |
/southafrica/ | English |
/spain/ | Español |
/sweden/ | Svensk |
/switzerland/de | Deutsch |
/switzerland/fr | Français |
/turkey/ | Türkçe |
/uk/ | English |
/argentina/ | Español |
/bolivia/ | Español |
/brasil/ | Português |
/centralamericaandthecaribbean/ | Spanish |
/centralamericaandthecaribbean/en | English |
/chile/ | Español |
/colombia/ | Español |
/ecuador/ | Español |
/mexico/ | Español |
/paraguay/ | Español |
/peru/ | Español |
/uruguay/ | Español |
/canada/ | English |
/canada/fr | Français |
/us/ | English |
stories | VIEW STORIES |
/colorful-life | Learn more about Cliff’s story, “A Colorful Life” |
/privacy-policy | Privacy Policy |
/legal-notice | Legal Notice |
domain: janssen.at
registrant: JAJ7513155-NICAT
admin-c: JAJ7513155-NICAT
tech-c: JAJN7513098-NICAT
nserver: ns1.jnj.com
nserver: ns3.jnj.com
nserver: ns5.jnj.com
changed: 20101008 14:52:53
source: AT-DOM
personname: Johnson and Johnson
organization: Johnson and Johnson
street address: One Johnson & Johnson Plaza
postal code: 08933
city: New Brunswick NJ
country: United States
phone: +17325243245
fax-no: +17325246341
e-mail: domains@corus.jnj.com
nic-hdl: JAJ7513155-NICAT
changed: 20101008 14:52:49
source: AT-DOM
personname: The Hostmaster
organization: Johnson and Johnson NCS.
street address: 1003 US Hway. 202 N
postal code: 08869
city: Raritan NJ
country: United States
phone: +18009002555
fax-no: +19086554126
e-mail: extdnsreqs@ncsus.jnj.com
nic-hdl: JAJN7513098-NICAT
changed: 20101008 14:26:36
source: AT-DOM
HTTP/1.1 200 OK
Date: Sun, 12 Jan 2020 14:25:14 GMT
Content-Type: text/html; charset=utf-8
Transfer-Encoding: chunked
Connection: keep-alive
Set-Cookie: __cfduid=db0254c635453d0de8b7cc3686feba5fd1578839112; expires=Tue, 11-Feb-20 14:25:12 GMT; path=/; domain=.janssen.com; HttpOnly; SameSite=Lax
Expires: Sun, 19 Nov 1978 05:00:00 GMT
Cache-Control: no-cache, must-revalidate
X-Content-Type-Options: nosniff
X-Frame-Options: SAMEORIGIN
Content-Language: en
X-UA-Compatible: IE=edge,chrome=IE8
X-Generator: Drupal 7 (http://drupal.org)
Link: ; rel="canonical"
X-Request-ID: v-58819910-3547-11ea-97e1-8bb5ac7431bd
X-AH-Environment: prod
X-Geo-Country: US
Vary: Accept-Encoding,X-Geo-Country
Via: varnish
X-Cache: MISS
CF-Cache-Status: MISS
Expect-CT: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
Server: cloudflare
CF-RAY: 553fcc679de4e1c6-ORD
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"